These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 21618258)

  • 1. Experience with local lymph node assay performance standards using standard radioactivity and nonradioactive cell count measurements.
    Basketter D; Kolle SN; Schrage A; Honarvar N; Gamer AO; van Ravenzwaay B; Landsiedel R
    J Appl Toxicol; 2012 Aug; 32(8):590-6. PubMed ID: 21618258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Further experience with the local lymph node assay using standard radioactive and nonradioactive cell count measurements.
    Kolle SN; Basketter D; Schrage A; Gamer AO; van Ravenzwaay B; Landsiedel R
    J Appl Toxicol; 2012 Aug; 32(8):597-607. PubMed ID: 22627909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of BALB/c mouse in the local lymph node assay:BrdU-ELISA for the prediction of the skin sensitizing potential of chemicals.
    Hou F; Xing C; Li B; Cheng J; Chen W; Zhang M
    J Pharmacol Toxicol Methods; 2015; 72():53-8. PubMed ID: 25600862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene expression profiles in auricle skin as a possible additional endpoint for determination of sensitizers: A multi-endpoint evaluation of the local lymph node assay.
    Tsuchiyama H; Maeda A; Nakajima M; Kitsukawa M; Takahashi K; Miyoshi T; Mutsuga M; Asaoka Y; Miyamoto Y; Oshida K
    Toxicol Lett; 2017 Oct; 280():133-141. PubMed ID: 28826779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel approach for classifying chemicals according to skin sensitizing potency by non-radioisotopic modification of the local lymph node assay.
    Takeyoshi M; Iida K; Shiraishi K; Hoshuyama S
    J Appl Toxicol; 2005; 25(2):129-34. PubMed ID: 15744759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advantage of using CBA/N strain mice in a non-radioisotopic modification of the local lymph node assay.
    Takeyoshi M; Noda S; Yamasaki K; Kimber I
    J Appl Toxicol; 2006; 26(1):5-9. PubMed ID: 16217858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Local lymph node assay (LLNA) for detection of sensitization capacity of chemicals.
    Gerberick GF; Ryan CA; Dearman RJ; Kimber I
    Methods; 2007 Jan; 41(1):54-60. PubMed ID: 16938465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and utilization of an ex vivo bromodeoxyuridine local lymph node assay protocol for assessing potential chemical sensitizers.
    Williams WC; Copeland C; Boykin E; Quell SJ; Lehmann DM
    J Appl Toxicol; 2015 Jan; 35(1):29-40. PubMed ID: 24532485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization and evaluation of a modified local lymph node assay using ATP content as a non-radio isotopic endpoint.
    Idehara K; Yamagishi G; Yamashita K; Ito M
    J Pharmacol Toxicol Methods; 2008; 58(1):1-10. PubMed ID: 18462956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance standards and alternative assays: practical insights from skin sensitization.
    Kolle SN; Basketter DA; Casati S; Stokes WS; Strickland J; van Ravenzwaay B; Vohr HW; Landsiedel R
    Regul Toxicol Pharmacol; 2013 Mar; 65(2):278-85. PubMed ID: 23279805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of the skin sensitization potency of eugenol and its dimers using a non-radioisotopic modification of the local lymph node assay.
    Takeyoshi M; Noda S; Yamazaki S; Kakishima H; Yamasaki K; Kimber I
    J Appl Toxicol; 2004; 24(1):77-81. PubMed ID: 14745850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of radioisotopic and non-radioisotopic versions of local lymph node assays for subcategorization of skin sensitizers compliant to UN GHS rev 4.
    Ha S; Ahn IY; Kim DE; Lee JK; Sohn S; Jung MS; Heo Y; Omori T; Bae S; Lim KM
    Regul Toxicol Pharmacol; 2017 Apr; 85():124-131. PubMed ID: 28193562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of BALB/c and CBA/J mice for the local lymph node assay using bromodeoxyuridine with flow cytometry (LLNA: BrdU-FCM).
    Lee YS; Yi JS; Seo SJ; Kim JH; Jung MS; Seo IK; Ahn I; Ko K; Kim TS; Lim KM; Sohn S
    Regul Toxicol Pharmacol; 2017 Feb; 83():13-22. PubMed ID: 27816673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of an ex vivo murine local lymph node assay: multiple endpoint comparison.
    Piccotti JR; Knight SA; Gillhouse K; Lagattuta MS; Bleavins MR
    J Appl Toxicol; 2006; 26(4):333-40. PubMed ID: 16705757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the skin sensitizing potential of unsaturated compounds as assessed by the murine local lymph node assay (LLNA) and the guinea pig maximization test (GPMT).
    Kreiling R; Hollnagel HM; Hareng L; Eigler D; Lee MS; Griem P; Dreessen B; Kleber M; Albrecht A; Garcia C; Wendel A
    Food Chem Toxicol; 2008 Jun; 46(6):1896-904. PubMed ID: 18343554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of an ex vivo local lymph node assay to assess contact hypersensitivity potential.
    Piccotti JR; Kawabata TT
    J Immunotoxicol; 2008 Jul; 5(3):271-7. PubMed ID: 18830887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intra-laboratory study to determine the reproducibility of LLNA:BrdU-ELISA for the prediction of the skin sensitizing potential of chemicals.
    Chen W; Xing C; Hou F
    J Pharmacol Toxicol Methods; 2016; 82():26-30. PubMed ID: 27456929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Skin sensitization potency of methyl methacrylate in the local lymph node assay: comparisons with guinea-pig data and human experience.
    Betts CJ; Dearman RJ; Heylings JR; Kimber I; Basketter DA
    Contact Dermatitis; 2006 Sep; 55(3):140-7. PubMed ID: 16918612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemical applicability domain of the Local Lymph Node Assay (LLNA) for skin sensitisation potency. Part 2. The biological variability of the murine Local Lymph Node Assay (LLNA) for skin sensitisation.
    Roberts DW; Api AM; Aptula AO
    Regul Toxicol Pharmacol; 2016 Oct; 80():255-9. PubMed ID: 27470439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunophenotyping does not improve predictivity of the local lymph node assay in mice.
    Strauss V; Kolle SN; Honarvar N; Dammann M; Groeters S; Faulhammer F; Landsiedel R; van Ravenzwaay B
    J Appl Toxicol; 2015 Apr; 35(4):434-45. PubMed ID: 25186098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.